LNC Therapeutics

Perhaps reflecting recent global big pharma interest in the sector, Chinese biotechs focused on radiopharmaceuticals have been extending their fundraising spree since March, with three major financing

Technology transfer from universities and other non-profit research institutions to private sector firms is core to the modern biopharma industry, but before the enactment of the Bayh-Dole Act in 1980

[Johnson & Johnson Innovation - JLABS] has been launching its JLABS sites within biotechnology hubs such as Boston, San Diego and San Francisco since 2012, but it chose Philadelphia as the site for it